Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...

Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...

A major focus of the review is on immune checkpoint pathways, such as PD-1/PD-L1, which tumors exploit ... chemokines, and signaling pathways in shaping the immune landscape of EC.

Cancer-associated fibroblasts (CAFs) play an important role in metastatic melanoma, and an enhanced understanding of that role could lead to important new therapeutic pathways, according to a new ...